Anti-Obesity Drug Discovery and Development: Volume 3

Volume in the series

Anti-Obesity Drug Discovery and Development

Publisher:Bentham Science

By: Atta-ur Rahman and M. Iqbal Choudhary

Paid access

|Jun 2017

E-Book €35.99Institutions €151.95

Description

Obesity is a complex health problem caused by a number of factors such as excessive food intake lack of physical activity genetic predisposition endocrine disorders medications and psychiatric illnesses. Onset of obesity in both the developing and the developed world has reached epidemic proportions. In response to this efforts to control and treat obesity have also been vigorously pursued ranging from raising awareness about lifestyle changes to the discovery and development of safe and effective anti-obesity drugs.
Anti-obesity Drug Discovery and Development is focused on this very important area of healthcare research. The third volume of this series is dedicated to anti-obesity treatments including updates on new therapeutics for obesity Nesfatin-1 and its therapeutic uses the role of proteomics in pediatric anti-obesity treatment the role of oxidative stress in childhood obesity and a review of data on gut microbiota as a treatment option for obesity.

Authors

Metrics

PDF ISBN: 978-1-68108-187-8

Publisher: Bentham Science

Publication date: 2017

Language: English

Pages: 243

Related subjects:

Medicine,

Clinical medicine,

Clinical medicine, other